ReviewJournal of neurology2011
Treatment of multiple sclerosis: current concepts and future perspectives.
Review in Journal of neurology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- Trial
- Anti-cytokine autoantibodies: mechanistic insights and disease associations.Nature reviews. Immunology · 2024Review
- White Matter Alterations Associated with Pro-inflammatory Cytokines in Patients with Major Depressive Disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2021Article
- Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?Frontiers in immunology · 2020Review
- Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis.Scientific reports · 2019Article
- Epidemiology and treatment of multiple sclerosis in elderly populations.Nature reviews. Neurology · 2019Review
- A survey of risk tolerance to multiple sclerosis therapies.Neurology · 2019Article
- Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis.Frontiers in neurology · 2019Article
- Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.Molecular neurobiology · 2016Review
- Multiple Sclerosis Therapy With Disease-Modifying Treatments in Germany: The PEARL (ProspEctive phArmacoeconomic cohoRt evaluation) Noninterventional Study Protocol.JMIR research protocols · 2016Article
- Activation of necroptosis in multiple sclerosis.Cell reports · 2015Article
- Neurobehavioral burden of multiple sclerosis with nanotheranostics.Neuropsychiatric disease and treatment · 2015Review
- Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.Proceedings of the National Academy of Sciences of the United States of America · 2014Article
- Article
- Article
- MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients.International journal of molecular sciences · 2013Article
- Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.Molecular immunology · 2013Article
- Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.Journal of immunology (Baltimore, Md. : 1950) · 2013Article
- [Vitamin D and multiple sclerosis : the role for risk of disease and treatment].Der Nervenarzt · 2013Review
- Can we prevent or treat multiple sclerosis by individualised vitamin D supply?The EPMA journal · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, several disease-modifying therapies for the treatment of multiple sclerosis are established and more are likely to be introduced. These treatment options differ with respect to their application profile, mechanism of action, efficacy, safety, and tolerance. Here, we review current concepts of MS therapies, report recent results of clinical trials, and discuss emerging treatment options.
Indexed as
Identifiers
21637950What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.